EX-FILING FEES 5 d231890dexfilingfees.htm EX-FILING FEES EX-FILING FEES

Exhibit 107

CALCULATION OF REGISTRATION FEE

Form S-8

(Form Type)

Fate Therapeutics, Inc.

(Exact name of Registrant as Specified in its Charter)

Newly Registered Securities

 

               

Security

Type

  

Security Class

Title

  

Fee

Calculation

Rule

   Amount
Registered(1)
  

Proposed
Maximum

Offering

Price Per

Share(2)

  

Maximum
Aggregate

Offering Price

   Fee Rate    Amount of
Registration
Fee
               
Equity    Common Stock, $0.001 par value per share, 2022 Stock Option and Incentive Plan    Rule 457(c) and Rule 457(h)    9,500,000(3)    $22.83    $216,885,000.00    $0.0000927    $20,105.24
         
Total Offering Amounts       $216,885,000.00      
         
Total Fees Previously Paid            
         
Total Fee Offsets            
         
Net Fee Due                   $20,105.24

 

(1)

Pursuant to Rule 416 under the Securities Act of 1933, as amended (the “Securities Act”), this registration statement shall also cover any additional shares of common stock which become issuable under the above-named plan by reason of any stock dividend, stock split, recapitalization or any other similar transaction effected without the receipt of consideration which results in an increase in the number of our outstanding shares of common stock.

(2)

Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457 of the Securities Act, and based on the average of the high and low sales prices of the registrant’s common stock, as quoted on the Nasdaq Global Market, on June 2, 2022.

(3)

Represents 9,500,000 shares of common stock that were reserved for issuance under the 2022 Stock Option and Incentive Plan.